The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Book Review
PreviousPrevious
Volume 332:897-898 March 30, 1995 Number 13

Polycythemia Vera and the Myeloproliferative Disorders

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
Edited by Louis R. Wasserman, Paul D. Berk, and Nathaniel I. Berlin. 361 pp., illustrated. Philadelphia, W.B. Saunders, 1995. $100. ISBN 0-7216-4213-6.

Overproduction of red cells resulting in erythrocytosis has been recognized by clinicians for more than 100 years, since the initial descriptions by Louis Henri Vaquez and then by William Osler. As pointed out in the preface to this book, physicians and medical scientists have been fascinated by polycythemia — not because of its public health consequences, but because of the interesting clinical and physiologic implications of this group of diseases. Studies of polycythemia have contributed directly to many advances in our understanding of hematopoiesis and the regulation of red-cell production, including the role of erythropoietin. Furthermore, confirmation of the clonal . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.